What is the share price of Coral Laboratories Ltd (CORALAB) today?
The share price of CORALAB as on 4th July 2025 is ₹594.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Coral Laboratories Ltd (CORALAB) share?
The past returns of Coral Laboratories Ltd (CORALAB) share are- Past 1 week: -3.00%
- Past 1 month: -6.75%
- Past 3 months: -16.63%
- Past 6 months: -24.07%
- Past 1 year: -13.54%
- Past 3 years: 145.52%
- Past 5 years: 198.27%
What are the peers or stocks similar to Coral Laboratories Ltd (CORALAB)?
The peers or stocks similar to Coral Laboratories Ltd (CORALAB) include:What is the market cap of Coral Laboratories Ltd (CORALAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Coral Laboratories Ltd (CORALAB) is ₹212.27 Cr as of 4th July 2025.What is the 52 week high and low of Coral Laboratories Ltd (CORALAB) share?
The 52-week high of Coral Laboratories Ltd (CORALAB) is ₹999 and the 52-week low is ₹567.15.What is the PE and PB ratio of Coral Laboratories Ltd (CORALAB) stock?
The P/E (price-to-earnings) ratio of Coral Laboratories Ltd (CORALAB) is 8.79. The P/B (price-to-book) ratio is 1.20.Which sector does Coral Laboratories Ltd (CORALAB) belong to?
Coral Laboratories Ltd (CORALAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Coral Laboratories Ltd (CORALAB) shares?
You can directly buy Coral Laboratories Ltd (CORALAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Coral Laboratories Ltd
CORALAB Share Price
CORALAB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
CORALAB Performance & Key Metrics
CORALAB Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
8.78 | 1.20 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
37.15 | 6.59 | 0.81% |
CORALAB Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
CORALAB Company Profile
The Company is engaged in the pharmaceutical business. The Company offers products in various categories like sterile, non sterile, nutraceutical and otc products catering to lifestyle segment.
CORALAB Forecast
CORALAB Forecasts
CORALAB
CORALAB
Income
Balance Sheet
Cash Flow
CORALAB Income Statement
CORALAB Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 98.84 | 96.94 | 96.24 | 76.47 | 100.36 | 81.38 | 85.05 | 90.29 | 124.11 | 124.12 | ||||||||||
Raw Materials | 51.33 | 52.54 | 50.76 | 42.97 | 50.11 | 39.01 | 42.11 | 40.38 | 89.54 | 89.53 | ||||||||||
Power & Fuel Cost | 1.84 | 1.84 | 1.85 | 1.82 | 2.05 | 2.55 | 3.10 | 3.05 | ||||||||||||
Employee Cost | 6.76 | 8.57 | 9.84 | 9.70 | 10.18 | 11.23 | 11.13 | 11.20 | ||||||||||||
Selling & Administrative Expenses | 3.76 | 5.01 | 6.53 | 6.45 | 9.32 | 9.61 | 9.55 | 8.39 | ||||||||||||
Operating & Other expenses | 8.83 | 9.17 | 9.68 | 4.22 | 9.05 | 5.00 | 8.43 | 4.57 | ||||||||||||
EBITDA | 26.32 | 19.81 | 17.58 | 11.31 | 19.65 | 13.98 | 10.73 | 22.70 | 34.57 | 34.59 | ||||||||||
Depreciation/Amortization | 1.56 | 1.56 | 1.90 | 2.01 | 1.98 | 1.99 | 2.18 | 1.98 | 2.01 | 2.01 | ||||||||||
PBIT | 24.76 | 18.25 | 15.68 | 9.30 | 17.67 | 11.99 | 8.55 | 20.72 | 32.56 | 32.58 | ||||||||||
Interest & Other Items | 0.20 | 0.20 | 0.17 | 0.19 | 0.04 | 0.14 | 0.34 | 0.00 | 0.10 | 0.10 | ||||||||||
PBT | 24.56 | 18.05 | 15.51 | 9.11 | 17.63 | 11.85 | 8.21 | 20.72 | 32.46 | 32.48 | ||||||||||
Taxes & Other Items | 8.27 | 5.60 | 5.29 | 1.99 | 4.06 | 2.81 | 1.78 | 4.94 | 8.31 | 8.31 | ||||||||||
Net Income | 16.29 | 12.45 | 10.22 | 7.12 | 13.57 | 9.04 | 6.43 | 15.78 | 24.15 | 24.17 | ||||||||||
EPS | 45.60 | 34.85 | 28.61 | 19.93 | 37.98 | 25.30 | 18.00 | 44.17 | 67.61 | 67.65 | ||||||||||
DPS | 5.00 | 2.00 | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | ||||||||||
Payout ratio | 0.11 | 0.06 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
CORALAB Company Updates
CORALAB Stock Peers
CORALAB Past Performance & Peer Comparison
CORALAB Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Coral Laboratories Ltd | 8.79 | 1.20 | — |
Sun Pharmaceutical Industries Ltd | 36.80 | 5.99 | 0.95% |
Cipla Ltd | 23.18 | 3.91 | 1.06% |
Torrent Pharmaceuticals Ltd | 59.65 | 16.63 | 0.95% |
CORALAB Stock Price Comparison
Compare CORALAB with any stock or ETFCORALAB Holdings
CORALAB Shareholdings
CORALAB Promoter Holdings Trend
CORALAB Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
CORALAB Institutional Holdings Trend
CORALAB Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
CORALAB Shareholding Pattern
CORALAB Shareholding Pattern
CORALAB Shareholding History
CORALAB Shareholding History
smallcases containing CORALAB stock
smallcases containing CORALAB stock
Looks like this stock is not in any smallcase yet.
CORALAB Events
CORALAB Events
CORALAB Dividend Trend
CORALAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
CORALAB Dividend Trend
CORALAB has not given any dividends in last 5 years
CORALAB Upcoming Dividends
CORALAB Upcoming Dividends
No upcoming dividends are available
CORALAB Past Dividends
CORALAB Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2024
Cash Dividend
Ex DateEx DateSep 19, 2019
Dividend/Share
₹2.00
Ex DateEx Date
Sep 19, 2019
Cash Dividend
Ex DateEx DateSep 18, 2018
Dividend/Share
₹2.00
Ex DateEx Date
Sep 18, 2018
Cash Dividend
Ex DateEx DateSep 11, 2017
Dividend/Share
₹5.00
Ex DateEx Date
Sep 11, 2017
Cash Dividend
Ex DateEx DateSep 16, 2016
Dividend/Share
₹3.00
Ex DateEx Date
Sep 16, 2016
CORALAB Stock News & Opinions
CORALAB Stock News & Opinions
Coral Laboratories announced that the Board of Directors of the Company at its meeting held on 30 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Coral Laboratories declined 51.12% to Rs 2.83 crore in the quarter ended March 2025 as against Rs 5.79 crore during the previous quarter ended March 2024. Sales declined 2.63% to Rs 28.13 crore in the quarter ended March 2025 as against Rs 28.89 crore during the previous quarter ended March 2024. For the full year,net profit rose 53.01% to Rs 24.16 crore in the year ended March 2025 as against Rs 15.79 crore during the previous year ended March 2024. Sales rose 37.47% to Rs 115.01 crore in the year ended March 2025 as against Rs 83.66 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales28.1328.89 -3 115.0183.66 37 OPM %9.5621.60 -22.8219.41 - PBDT5.138.33 -38 35.2522.87 54 PBT4.627.83 -41 33.2420.89 59 NP2.835.79 -51 24.1615.79 53 Powered by Capital Market - Live
Coral Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
Net profit of Coral Laboratories rose 184.26% to Rs 6.14 crore in the quarter ended December 2024 as against Rs 2.16 crore during the previous quarter ended December 2023. Sales rose 27.16% to Rs 22.99 crore in the quarter ended December 2024 as against Rs 18.08 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales22.9918.08 27 OPM %27.4511.62 - PBDT8.813.54 149 PBT8.313.05 172 NP6.142.16 184 Powered by Capital Market - Live
Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live
Net profit of Coral Laboratories rose 6.33% to Rs 6.38 crore in the quarter ended September 2024 as against Rs 6.00 crore during the previous quarter ended September 2023. Sales rose 39.22% to Rs 32.23 crore in the quarter ended September 2024 as against Rs 23.15 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.2323.15 39 OPM %20.2026.57 - PBDT9.047.96 14 PBT8.537.52 13 NP6.386.00 6 Powered by Capital Market - Live
Coral Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024.Powered by Capital Market - Live
Coral Laboratories will hold a meeting of the Board of Directors of the Company on 24 September 2024.Powered by Capital Market - Live
Coral Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Coral Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.17%, vs industry avg of 10.14%
Over the last 5 years, market share stayed at 0.03%
Over the last 5 years, net income has grown at a yearly rate of 27.67%, vs industry avg of 20.01%